Mitesco, Inc. (MITI)
OTCMKTS · Delayed Price · Currency is USD
0.0947
-0.0249 (-20.82%)
At close: Dec 19, 2025
Mitesco Market Cap
Mitesco has a market cap or net worth of $1.45 million as of December 19, 2025. Its market cap has decreased by -68.34% in one year.
Market Cap
1.45M
Enterprise Value
2.57M
Revenue
52.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since December 11, 2015, Mitesco's market cap has increased from 636.26K to 1.45M, an increase of 128.37%. That is a compound annual growth rate of 8.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.45M | -67.31% |
| Dec 31, 2024 | 4.44M | 2,560.84% |
| Dec 29, 2023 | 167.04K | -96.60% |
| Dec 30, 2022 | 4.91M | -85.96% |
| Dec 31, 2021 | 34.96M | 770.80% |
| Dec 31, 2020 | 4.01M | 10.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 820.05M |
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 190.62M |